Inhibitory Effects of the Extracts of Juglans sigillata Green Husks on the Proliferation, Migration and Survival of KYSE150 and EC9706 Human Esophageal Cancer Cell Lines

References

• Pennathur A, Gibson MK, Jobe BA, and Luketich JD: Oesophageal carcinoma. Lancet 381, 400–412, 2013. doi: 10.1016/S0140-6736(12)60643-6.
   PubMed Web of Science ®Google Scholar
• Zhu YH, Fu L, Chen L, Qin YR, and Liu H: Downregulation of the novel tumor suppressor diras1 predicts poor prognosis in esophageal squamous cell carcinoma. Cancer Res 73, 2298–2309, 2013.
   PubMed Web of Science ®Google Scholar
• Hongo M, Nagasaki Y, and Shoji T: Epidemiology of esophageal cancer: orient to occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 24, 729–735, 2009.
   PubMed Web of Science ®Google Scholar
• Stoner GD and Gupta A: Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis 22, 1737–1746, 2001.
   PubMed Web of Science ®Google Scholar
• Tang KH, Dai YD, Tong M, Chan YP, Kwan PS, et al.: A cd90(+) tumor-initiating cell population with an aggressive signature and metastatic capacity in esophageal cancer. Cancer Res 73, 2322–2332, 2013.
   PubMed Web of Science ®Google Scholar
• Stewart DJ: Mechanisms of resistance to cisplatin and carboplatin. Crit Rev Oncol Hematol 63, 12–31, 2007.
   PubMed Web of Science ®Google Scholar
• Zhang T, Zhao T, Xu X, Gu X, and Pan Y: Efficacy and sideeffects of docetaxel combined with cisplatin on the treatment of local advanced esophageal cancer with concomitant radiation therapy. Zhonghua Zhong Liu Za Zhi 32, 791–794, 2010.
   PubMedGoogle Scholar
• Biagi JJ, Raphael MJ, Mackillop WJ, Kong W, King WD, et al.: Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. Breast Cancer Res Treat 160, 17, 2016.
   PubMedGoogle Scholar
• Wang CZ, Calway T, and Yuan CS: Herbal medicines as adjuvants for cancer therapeutics. Am J Chin Med 40, 657–669, 2012.
   PubMed Web of Science ®Google Scholar
• Hideyuki I, Takahiro O, Toshiyuki F, Tsutomu H, and Takashi YJ: Two novel dicarboxylic Acid derivatives and a new dimeric hydrolyzable tannin from walnuts. J Agric Food Chem 55, 672–679, 2007.
   PubMed Web of Science ®Google Scholar
• Lee KS, Li G, Kim SH, Lee CS, Woo MH, et al.: Cytotoxic diarylheptanoids from the roots of Juglans mandshurica. J Nat Prod 65, 1707–1708, 2002.
   PubMed Web of Science ®Google Scholar
• Erdemoglu N, Küpeli E, and Yeşilada E: Anti-inflammatory and antinociceptive activity assessment of plants used as remedy in Turkish folk medicine. J Ethnopharmacol 89, 123–129, 2003.
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhao P, Li XC, Jacob M, Yang CR, et al.: New α-tetralone galloylglucosides from the fresh pericarps of Juglans sigillata. Hca 93, 265–271, 2010.
   Web of Science ®Google Scholar
• Si CL, Xu J, and Jiang JZ: Antibacterial capacity of Juglans sigillata green husks. Plant Med 72, 1418, 2011.
   Google Scholar
• Si C-L, Qin P-P, Hu H-Y, Jiang J-Z, and Ni Y-H: Low molecular weight extractives from green husks of Juglans sigillata and their antioxidant activities. J Biobased Mat Bioenergy 5, 287–292, 2011.
   Web of Science ®Google Scholar
• Fuchs-Tarlovsky V: Role of antioxidants in cancer therapy. Nutrition 29, 15–21, 2013.
   PubMed Web of Science ®Google Scholar
• Lawless MW, O'Byrne KJ, and Gray SG: Targeting oxidative stress in cancer. Expert Opin Ther Targets 14, 1225–1245, 2010.
   PubMed Web of Science ®Google Scholar
• Huang J, Yang Z, Zhu R, Xinxin Q, and Yaqiu W: Efcient heterologous expression of an alkaline lipase and its application in hydrolytic production of free astaxanthin. Biotechnol Biofuels 11, 181, 2018. doi: 10.1186/s13068-018-1180-2.
   PubMed Web of Science ®Google Scholar
• Thomford NE, Senthebane DA, Rowe A, Munro D, Seele P, et al.: Natural products for drug discovery in the 21st century: innovations for novel drug discovery. IJMS 19, 1578, 2018. doi: 10.3390/ijms19061578.
   Web of Science ®Google Scholar
• Choi HW, Tian M, Song F, Venereau E, Preti A, et al.: Aspirin's active metabolite salicylic acid targets high mobility group box 1 to modulate inflammatory responses. Mol Med 21, 526–535, 2015.
   PubMed Web of Science ®Google Scholar
• Kim JK and Diehl JA: Nuclear cyclin D1: an oncogenic driver in human cancer. J Cell Physiol 220, 292–296, 2009.
   PubMed Web of Science ®Google Scholar
• Li L, Dai HJ, Ye M, Wang SL, Xiao XJ, et al.: Lycorine induces cell-cycle arrest in the G0/G1 phase in K562 cells via HDAC inhibition. Cancer Cell Int 12, 49, 2012. doi: 10.1186/1475-2867-12-49.
   PubMed Web of Science ®Google Scholar
• Chipuk JE and Green DR: Cytoplasmic p53: bax and forward. Cell Cycle 3, 429–431, 2004.
   PubMed Web of Science ®Google Scholar
• Shen J, Xu L, Owonikoko TK, Sun SY, Khuri FR, et al.: NNK promotes migration and invasion of lung cancer cells through activation of c-Src/PKCι/FAK loop. Cancer Lett 318, 106–113, 2012.
   PubMed Web of Science ®Google Scholar
• Bianchi Smiraglia A, Paesante S, and Bakin AV: Integrin β5 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways. Oncogene 32, 3049–3058, 2013.
   PubMed Web of Science ®Google Scholar
• Park C, Choi YW, Hyun SK, Kwon HJ, Hwang HJ, et al.: Induction of G1 arrest and apoptosis by schisandrin C isolated from Schizandra chinensis Baill in human leukemia U937 cells. Int J Mol Med 24, 495–502, 2009.
   PubMed Web of Science ®Google Scholar
• Eichhorn JM, Alford SE, Sakurikar N, and Chambers TC: Molecular analysis of functional redundancy among anti-apoptotic Bcl-2 proteins and its role in cancer cell survival. Exp Cell Res 322, 415–424, 2014.
   PubMed Web of Science ®Google Scholar
• Lee HL, Lin CS, Kao SH, and Chou MC: Gallic acid induces G1 phase arrest and apoptosis of triple-negative breast cancer cell MDA-MB-231 via p38 mitogen-activated protein kinase/p21/p27 axis. Anti-Cancer Drugs 28, 1150–1156, 2017.
   PubMed Web of Science ®Google Scholar
• Subramanian AP, Jaganathan SK, Mandal M, Supriyanto E, and Muhamad II: Gallic acid induced apoptotic events in HCT-15 colon cancer cells. Wjg 22, 3952–3961, 2016.
   PubMed Web of Science ®Google Scholar
• Liu Z, Li D, Yu L, and Niu F: Gallic acid as a cancer-selective agent induces apoptosis in pancreatic cancer cells. Chemotherapy 58, 185–194, 2012.
   PubMed Web of Science ®Google Scholar
• Yeh RD1, Chen JC, Lai TY, Yang JS, Yu CS, et al.: Gallic acid induces G0/G1 phase arrest and apoptosis in human leukemia HL-60 cells through inhibiting cyclin D and E, and activating mitochondria-dependent pathway. Anticancer Res 31, 2821–2832, 2011.
   PubMed Web of Science ®Google Scholar
• Huang PJ, Hseu YC, Lee MS, Senthil Kumar KJ, Wu CR, et al.: In vitro and in vivo activity of gallic acid and Toona sinensis leaf extracts against HL-60 human premyelocytic leukemia. Food Chem Toxicol 50, 3489–3497, 2012.
   PubMed Web of Science ®Google Scholar
• Ou TT, Wang CJ, Lee YS, Wu CH, and Lee HJ: Gallic acid induces G2/M phase cell cycle arrest via regulating 14-3-3β release from Cdc25C and Chk2 activation in human bladder transitional carcinoma cells. Mol Nutr Food Res 54, 1781–1790, 2010.
   PubMed Web of Science ®Google Scholar
• Agarwal C, Tyagi A, and Agarwal R: Gallic acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via ATM-Chk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinoma DU145 cells. Mol Cancer Ther 5, 3294–3302, 2006.
   PubMed Web of Science ®Google Scholar
• Kuo C, Lai K, Ma Y, Weng S, Lin J, et al.: Gallic acid inhibits migration and invasion of SCC-4 human oral cancer cells through actions of NF-κB, Ras and matrix metalloproteinase-2 and -9. Oncol Rep 31, 355–361, 2014.
   Web of Science ®Google Scholar